DiGeorge syndrome || 22q11. 2 deletion syndrome || Immunodeficiency

DiGeorge syndrome || 22q11. 2 deletion syndrome || Immunodeficiency

Understanding DiGeorge Syndrome

Overview of DiGeorge Syndrome

  • DiGeorge syndrome, also known as 22q 11.2 deletion syndrome, is caused by the deletion of a small segment of chromosome 22.
  • It is characterized as an inherited immunodeficiency disorder, primarily due to poorly developed or absent thymus glands leading to T-cell production defects.

Distinct Facial Features

  • Patients with DiGeorge syndrome often exhibit distinct facial features: low-set ears, short eye openings, enlarged nose tips, hooded eyes, and elongated faces.

Genetic Implications

  • The deletion at locus 22q11.2 affects over 20 genes; notably the TBX1 gene which plays a crucial role in developing various structures including the heart and thymus.
  • The absence of the TBX1 gene leads to significant developmental issues in critical organs such as the heart (e.g., ventricular septal defects).

Associated Complications

  • Other complications include thyroid and parathyroid gland issues and physical anomalies like cleft palates that can cause swallowing difficulties and speech problems.

Immunological Challenges

  • Most patients experience variable degrees of immunodeficiency due to absent or underdeveloped thymus glands affecting T-cell mediated immunity.
  • Thymic transplantation and passive antibody treatments may provide temporary relief but are not long-term solutions for compromised immune systems.

Summary Insights

Video description

DiGeorge syndrome, also known as 22q11. 2 deletion syndrome, is a syndrome caused by the deletion of a small segment of chromosome 22. While the symptoms can vary, they often include congenital heart problems, specific facial features, frequent infections, developmental delay, learning problems and cleft palate.